logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 1
  • 1
    Tucat, Christian
    Born in September 1969
    Individual (14 offsprings)
    Officer
    2023-12-05 ~ now
    OF - Director → CIF 0
    Christian Tucat
    Born in September 1969
    Individual (14 offsprings)
    Person with significant control
    2023-12-05 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

PHARMX CONSULTING PARTNERS LIMITED

Period: 2023-12-05 ~ now
Company number: 15330131
Registered name
PHARMX CONSULTING PARTNERS LIMITED - now
Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
Brief company account
Property, Plant & Equipment
611 GBP2024-12-31
Debtors
6,021 GBP2024-12-31
Cash at bank and in hand
73,324 GBP2024-12-31
Current Assets
79,345 GBP2024-12-31
Creditors
Current, Amounts falling due within one year
-75,260 GBP2024-12-31
Net Current Assets/Liabilities
4,085 GBP2024-12-31
Total Assets Less Current Liabilities
4,696 GBP2024-12-31
Equity
Called up share capital
100 GBP2024-12-31
Retained earnings (accumulated losses)
4,596 GBP2024-12-31
Equity
4,696 GBP2024-12-31
Average Number of Employees
22023-12-05 ~ 2024-12-31
Property, Plant & Equipment - Gross Cost
Other
912 GBP2024-12-31
0 GBP2023-12-04
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
301 GBP2024-12-31
0 GBP2023-12-04
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
301 GBP2023-12-05 ~ 2024-12-31
Property, Plant & Equipment
Other
611 GBP2024-12-31
Trade Debtors/Trade Receivables
Current
6,021 GBP2024-12-31
Trade Creditors/Trade Payables
Current
21,113 GBP2024-12-31
Other Creditors
Current
48,858 GBP2024-12-31
Creditors
Current
75,260 GBP2024-12-31
Par Value of Share
Class 1 ordinary share
1 GBP2023-12-05 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2024-12-31

  • PHARMX CONSULTING PARTNERS LIMITED
    Info
    Registered number 15330131
    The Old Rectory, Church Street, Weybridge, Surrey KT13 8DE
    PRIVATE LIMITED COMPANY incorporated on 2023-12-05 (2 years 6 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-12-04
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.